Globe Life (GL) Stock Price, News & Analysis

Company Overview

Globe Life Inc. (NYSE: GL) is an insurance holding company that provides individual life and supplemental health insurance products through a network of wholly owned subsidiaries. Its offerings are designed primarily for middle-income households and include term and whole life insurance, mortgage protection coverage, accident and supplemental health insurance, Medicare supplement policies, and annuities.

The company markets its products through several distribution channels, including exclusive and independent agency networks, direct-to-consumer sales, and workplace or union-affiliated programs. Its principal insurance businesses operate under brands such as Globe Life, American Income Life, Liberty National, Family Heritage Life, and United American.

Globe Life traces its history to 1900 and was formerly known as Torchmark Corporation before adopting the Globe Life name in 2019. The company is headquartered in McKinney, Texas, and primarily serves customers across the United States through its insurance subsidiaries and sales organizations.

Key Stats

• Today's Range: $169.20 to $171.03
• 50-Day Range: $163.61 to $181.07
• 52-Week Range: $127.85 to $191.55
• Volume: 472,532 shs
• Average Volume: 455,941 shs
• Market Capitalization: $13.01 billion
• P/E Ratio: 11.24
• Dividend Yield: 0.78%
• Price Target: $189.56
• Consensus Rating: Moderate Buy

Globe Life Stock Analysis - MarketRank™

Globe Life scored higher than 85% of companies evaluated by MarketBeat, and ranked 247th out of 851 stocks in the finance sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Globe Life has received a consensus rating of Moderate Buy. The company's average rating score is 2.91, and is based on 1 strong buy rating, 8 buy ratings, 2 hold ratings, and no sell ratings.

Upside Potential

Globe Life has a consensus price target of $189.56, representing about 11.9% upside from its current price of $169.33.

Amount of Analyst Coverage

Globe Life has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 5.16%

Earnings Growth

Earnings for Globe Life are expected to grow by 5.16% in the coming year, from $15.70 to $16.51 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Globe Life is 11.24, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 36.54.

Price to Earnings Ratio vs. Sector

The P/E ratio of Globe Life is 11.24, which means that it is trading at a less expensive P/E ratio than the Finance sector average P/E ratio of about 23.21.

Price to Book Value per Share Ratio

Globe Life has a P/B Ratio of 2.23. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

2.85% of the float of Globe Life has been sold short.

Short Interest Ratio / Days to Cover

Globe Life has a short interest ratio ("days to cover") of 4.48.

Change versus previous month

Short interest in Globe Life has recently increased by 3.74%, indicating that investor sentiment is decreasing.

Dividend

• Score: 3.3 / 5
• Dividend Strength: Strong

Dividend Yield

Globe Life has a dividend yield of 0.78%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Globe Life has been increasing its dividend for 20 years.

Dividend Coverage

The dividend payout ratio of Globe Life is 8.76%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Globe Life will have a dividend payout ratio of 8.00% next year. This indicates that Globe Life will be able to sustain or increase its dividend.

News and Social Media

• Score: 3.4 / 5
• News Sentiment: 0.47

News Sentiment

Globe Life has a news sentiment score of 0.47. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Finance companies.

News Coverage This Week

MarketBeat has tracked 13 news articles for Globe Life this week, compared to 5 articles on an average week.

Search Interest

10 people have searched for GL on MarketBeat in the last 30 days. This is an increase of 67% compared to the previous 30 days.

MarketBeat Follows

3 people have added Globe Life to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days.

Company Ownership

• Score: 1.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Globe Life insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $25,793,717.00 in company stock.

Percentage Held by Insiders

2.11% of the stock of Globe Life is held by insiders.

Percentage Held by Institutions

81.61% of the stock of Globe Life is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Record date for 7/31 Dividend: 7/06/2026
• Ex-Dividend for 7/31 Dividend: 7/06/2026
• Dividend Payable: 7/31/2026
• Record date for 10/30 Dividend: 10/05/2026
• Ex-Dividend for 10/30 Dividend: 10/05/2026
• Last Earnings: 10/21/2026
• Today: 10/22/2026
• Dividend Payable: 10/30/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Finance
• Industry: Insurance
• Sub-Industry: Life & Health Insurance
• Current Symbol: NYSE:GL
• CIK: 320335
• Web: www.globelifeinsurance.com
• Phone: (972) 569-4000
• Fax: 972-569-3282
• Employees: 3,695
• Year Founded: 1951

Price Target and Rating

• Average Price Target for Globe Life: $189.56
• High Price Target: $225.00
• Low Price Target: $157.00
• Potential Upside/Downside: +11.9%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.91
• Research Coverage: 11 Analysts

Profitability

• EPS (Trailing Twelve Months): $15.06
• Trailing P/E Ratio: 11.24
• Forward P/E Ratio: 10.79
• P/E Growth: N/A
• Net Income: $1.16 billion
• Net Margins: 19.58%
• Pretax Margin: 24.15%
• Return on Equity: 20.52%
• Return on Assets: 3.96%

Debt

• Debt-to-Equity Ratio: 0.43
• Current Ratio: 0.07
• Quick Ratio: 0.07

Sales & Book Value

• Annual Sales: $5.99 billion
• Price / Sales: 2.17
• Cash Flow: $20.88 per share
• Price / Cash Flow: 8.11
• Book Value: $75.98 per share
• Price / Book: 2.23

Miscellaneous

• Outstanding Shares: 76,850,000
• Free Float: 75,227,000
• Market Cap: $13.01 billion
• Optionable: Optionable
• Beta: 0.44